This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2gwv
From Proteopedia
(Difference between revisions)
m (Protected "2gwv" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | + | ==STRUCTURE MODEL OF HAMSTER ARYLAMINE N-ACETYLTRANSFERASE 2== | |
| + | <StructureSection load='2gwv' size='340' side='right' caption='[[2gwv]]' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2GWV FirstGlance]. <br> | ||
| + | </td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2gwv FirstGlance], [http://www.ebi.ac.uk/pdbsum/2gwv PDBsum]</span></td></tr> | ||
| + | <table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Arylamine N-acetyltransferases (NATs) catalyze the acetylation of arylamines, a key step in the detoxification of many carcinogens. The determinants of NAT substrate specificity are not known, yet this knowledge is required to understand why NAT enzymes acetylate some arylamines, but not others. Here, we use NMR spectroscopy and homology modeling to reveal the structural determinants of arylamine acetylation by NATs. In particular, by using chemical shift perturbation analysis, we have identified residues that play a critical role in substrate binding and catalysis. This study reveals why human NAT1 acetylates the sunscreen additive p-aminobenzoic acid and tobacco smoke carcinogen 4-aminobiphenyl, but not o-toluidine and other arylamines linked to bladder cancer. Our results represent an important step toward predicting whether arylamines present in new products can be detoxified by mammalian NATs. | ||
| - | + | NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.,Zhang N, Liu L, Liu F, Wagner CR, Hanna PE, Walters KJ J Mol Biol. 2006 Oct 13;363(1):188-200. Epub 2006 Aug 15. PMID:16959263<ref>PMID:16959263</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | == | + | == References == |
| - | + | <references/> | |
| - | + | __TOC__ | |
| - | + | </StructureSection> | |
| - | + | ||
| - | < | + | |
[[Category: Hanna, P E]] | [[Category: Hanna, P E]] | ||
[[Category: Liu, F]] | [[Category: Liu, F]] | ||
Revision as of 04:01, 29 September 2014
STRUCTURE MODEL OF HAMSTER ARYLAMINE N-ACETYLTRANSFERASE 2
| |||||||||||
Categories: Hanna, P E | Liu, F | Liu, L | Wagner, C R | Walters, K J | Zhang, N
